Pharmacologic Properties of KT2–962 (6‐Isopropyl‐3‐[4‐(p‐Chlorobenzenesulfonylamino)‐Butyl]‐ Azulene‐1‐Sulfonic Acid Sodium Salt); a New TXA2/Prostaglandin Endoperoxide Receptor Antagonist